Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
Saved in:
| Title: | Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors. |
|---|---|
| Authors: | Seban, Romain-David1 (AUTHOR), Mezquita, Laura2 (AUTHOR), Berenbaum, Arnaud1 (AUTHOR), Dercle, Laurent3 (AUTHOR), Botticella, Angela4 (AUTHOR), Le Pechoux, Cécile4 (AUTHOR), Caramella, Caroline5 (AUTHOR), Deutsch, Eric4,6,7 (AUTHOR), Grimaldi, Serena1 (AUTHOR), Adam, Julien8 (AUTHOR), Ammari, Samy5 (AUTHOR), Planchard, David2 (AUTHOR), Leboulleux, Sophie1 (AUTHOR), Besse, Benjamin2,7 (AUTHOR) Benjamin.BESSE@gustaveroussy.fr |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. May2020, Vol. 47 Issue 5, p1147-1157. 11p. 2 Diagrams, 3 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
